Corporate Profile for V.I. Technologies, dated Oct. 2, 1998.

MELVILLE, N.Y.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   Oct. 2, 1998

Company Name:          V.I. Technologies, Inc.

Address:          155 Duryea Road
                  Melville, NY 11747

Main Telephone
 Number:          516/752-7314

Chief Executive
 Officer:          John R. Barr

Chief Financial
 Officer:          Thomas T. Higgins

Investor Relations
 Contact:          Leslie A. Schupak
 Business number: 212/896-1207
 e-mail address:  [e-mail]
Public Relations
 Contact:          Stephanie Battles
 Business number: 212/896-1228
 e-mail address:  [e-mail]
Trading Symbol/
 Exchange:          NASDAQ:VITX

Industry:          Biotechnology
Market Makers:          Knight Securities LP; Instinet Corporation;
Fahnestock & Co., Inc.; SG Cowen Securities; Herzog, Heine, Geuld,
Inc.; Warburg Dillon Read, LLC; Island Corporation; Sherwood
Securities Corp.

    Company description: VITEX is a leading developer of a broad
portfolio of blood products and systems using its proprietary viral
inactivation technologies. These technologies are intended to address
the risk of contamination in blood products, including plasma, plasma
derivatives, red blood cells and platelets.
52 Week Price Range:               $49/16-175/8
Current Price:                       $51/8
Market Capitalization:               $62.9 million
Shares Outstanding as of 8/4:  12.2 million

 Fiscal Year Ending:               December 31
 FY 1997 Revenues:              ($17.07 million)
 Earnings Per Share:              ($2.04)
 Float:                        12.27 million